A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer Article

Industry Collaboration

cited authors

  • Treat, Joseph; Edelman, Martin J.; Belani, Chandra P.; Socinski, Mark A.; Monberg, Matthew J.; Chen, Ruqin; Obasaju, Coleman K.; Alpha Oncology Res Network

authors

Publication Date

  • December 1, 2010

webpage

published in

category

keywords

  • Carboplatin
  • Gemcitabine
  • Histology
  • NSCLC
  • Non-platinum doublets
  • Paclitaxel
  • Phase III
  • Squamous

start page

  • 340

end page

  • 346

volume

  • 70

issue

  • 3